Stoke Therapeutics: Q1 Earnings Insights

Stoke Therapeutics STOK reported its Q1 earnings results on Thursday, May 4, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Stoke Therapeutics beat estimated earnings by 23.19%, reporting an EPS of $-0.53 versus an estimate of $-0.69.

Revenue was up $2.51 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 0.11% drop in the share price the next day.

Here's a look at Stoke Therapeutics's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.70 -0.68 -0.71 0.36
EPS Actual -0.65 -0.66 -0.63 -0.66
Revenue Estimate 2.58M 2.45M 2.35M 40.00M
Revenue Actual 3.27M 2.90M 3.23M 3.00M

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Stoke Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

STOK Logo
STOKStoke Therapeutics Inc
$11.59-%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
28.55
Growth
Not Available
Quality
Not Available
Value
73.01
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...